These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12439362)

  • 1. Radiocontrast-induced acute renal failure: allocations and outcomes.
    Mehran R; Ashby DT
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past and present attempts to prevent radiocontrast nephropathy.
    Bailey SR
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S14-8. PubMed ID: 12439363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A; Epstein DL; Epstein M
    J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiocontrast nephropathy: the dye is not cast.
    Lepor NE
    Rev Cardiovasc Med; 2000; 1(1):43-54. PubMed ID: 12457151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
    Duong MH; MacKenzie TA; Malenka DJ
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephropathy caused by radiocontrast media].
    Kolarz M; Sułowicz W
    Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
    Madyoon H
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
    Mathur VS
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of radiocontrast-induced nephropathy.
    Baker CS
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):532-8. PubMed ID: 12652507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contrast-induced acute renal failure].
    Giannattasio M
    G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
    Kini AA; Sharma SK
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
    Samuels J; Finkel K; Gubert M; Johnson T; Shaw A
    Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast nephropathy: review focusing on prevention.
    Maeder M; Klein M; Fehr T; Rickli H
    J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
    Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
    Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fenoldopam: potential clinical applications in heart surgery].
    Shorten GD
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):487-91. PubMed ID: 11792308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of intravenous contrast-induced nephropathy in hospital inpatients.
    Kakkar R; Sobieszczyk P; Binkert CA; Faxon DP; Mortele KJ; Singh AK
    Crit Pathw Cardiol; 2008 Mar; 7(1):1-4. PubMed ID: 18458660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiocontrast-induced nephropathy.
    Porter GA
    Nephrol Dial Transplant; 1994; 9 Suppl 4():146-56. PubMed ID: 7800248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.